Blood microRNA testing in participants with suspicious low-dose CT findings: follow-up of the BioMILD lung cancer screening trial

https://www.thelancet.com/journals/lanepe/article/PIIS2666-7762(24)00237-0/fulltext?dgcid=hubspot_update_feature_updatealerts_lanepe&utm_campaign=update-lanepe&utm_medium=email&_hsenc=p2ANqtz-8b7S34IMZIVz97CDbmaKW2kG_E7ME9CM9We-yJ9J7z3j4p9fI2DESxJIpweVQ6ogJUUQV4jhMV3nRFXvLTHmj_kuS0fw&_hsmi=333574938&utm_content=333538501&utm_source=hs_email